ID   MRP2_HUMAN              Reviewed;        1545 AA.
AC   Q92887; B2RMT8; Q14022; Q5T2B1; Q92500; Q92798; Q99663; Q9UMS2;
DT   15-JUL-1998, integrated into UniProtKB/Swiss-Prot.
DT   05-OCT-2010, sequence version 3.
DT   10-MAY-2017, entry version 175.
DE   RecName: Full=Canalicular multispecific organic anion transporter 1;
DE   AltName: Full=ATP-binding cassette sub-family C member 2;
DE   AltName: Full=Canalicular multidrug resistance protein;
DE   AltName: Full=Multidrug resistance-associated protein 2;
GN   Name=ABCC2; Synonyms=CMOAT, CMOAT1, CMRP, MRP2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND VARIANT PHE-39.
RX   PubMed=8797578;
RA   Taniguchi K., Wada M., Kohno K., Nakamura T., Kawabe T., Kawakami M.,
RA   Kagotani K., Okumura K., Akiyama S., Kuwano M.;
RT   "A human canalicular multispecific organic anion transporter (cMOAT)
RT   gene is overexpressed in cisplatin-resistant human cancer cell lines
RT   with decreased drug accumulation.";
RL   Cancer Res. 56:4124-4129(1996).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND VARIANTS PHE-39; GLU-1188 AND
RP   TYR-1515.
RA   Kool M., de Haas M., Ponne N.J., Paulusma C.C., Oude-Elferink R.P.J.,
RA   Baas F., Borst P.;
RL   Submitted (FEB-1996) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND VARIANT PHE-39.
RX   PubMed=8662992; DOI=10.1074/jbc.271.25.15091;
RA   Buechler M., Koenig J., Brom M., Kartenbeck J., Spring H., Horie T.,
RA   Keppler D.;
RT   "cDNA cloning of the hepatocyte canalicular isoform of the multidrug
RT   resistance protein, cMrp, reveals a novel conjugate export pump
RT   deficient in hyperbilirubinemic mutant rats.";
RL   J. Biol. Chem. 271:15091-15098(1996).
RN   [4]
RP   SEQUENCE REVISION.
RA   Keppler D.;
RL   Submitted (AUG-1996) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANTS PHE-39 AND DJS
RP   1392-ARG-MET-1393 DEL.
RX   PubMed=10464142; DOI=10.1016/S0016-5085(99)70459-2;
RA   Tsujii H., Koenig J., Rost D., Stoeckel B., Leuschner U., Keppler D.;
RT   "Exon-intron organization of the human multidrug-resistance protein 2
RT   (MRP2) gene mutated in Dubin-Johnson syndrome.";
RL   Gastroenterology 117:653-660(1999).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15164054; DOI=10.1038/nature02462;
RA   Deloukas P., Earthrowl M.E., Grafham D.V., Rubenfield M., French L.,
RA   Steward C.A., Sims S.K., Jones M.C., Searle S., Scott C., Howe K.,
RA   Hunt S.E., Andrews T.D., Gilbert J.G.R., Swarbreck D., Ashurst J.L.,
RA   Taylor A., Battles J., Bird C.P., Ainscough R., Almeida J.P.,
RA   Ashwell R.I.S., Ambrose K.D., Babbage A.K., Bagguley C.L., Bailey J.,
RA   Banerjee R., Bates K., Beasley H., Bray-Allen S., Brown A.J.,
RA   Brown J.Y., Burford D.C., Burrill W., Burton J., Cahill P., Camire D.,
RA   Carter N.P., Chapman J.C., Clark S.Y., Clarke G., Clee C.M., Clegg S.,
RA   Corby N., Coulson A., Dhami P., Dutta I., Dunn M., Faulkner L.,
RA   Frankish A., Frankland J.A., Garner P., Garnett J., Gribble S.,
RA   Griffiths C., Grocock R., Gustafson E., Hammond S., Harley J.L.,
RA   Hart E., Heath P.D., Ho T.P., Hopkins B., Horne J., Howden P.J.,
RA   Huckle E., Hynds C., Johnson C., Johnson D., Kana A., Kay M.,
RA   Kimberley A.M., Kershaw J.K., Kokkinaki M., Laird G.K., Lawlor S.,
RA   Lee H.M., Leongamornlert D.A., Laird G., Lloyd C., Lloyd D.M.,
RA   Loveland J., Lovell J., McLaren S., McLay K.E., McMurray A.,
RA   Mashreghi-Mohammadi M., Matthews L., Milne S., Nickerson T.,
RA   Nguyen M., Overton-Larty E., Palmer S.A., Pearce A.V., Peck A.I.,
RA   Pelan S., Phillimore B., Porter K., Rice C.M., Rogosin A., Ross M.T.,
RA   Sarafidou T., Sehra H.K., Shownkeen R., Skuce C.D., Smith M.,
RA   Standring L., Sycamore N., Tester J., Thorpe A., Torcasso W.,
RA   Tracey A., Tromans A., Tsolas J., Wall M., Walsh J., Wang H.,
RA   Weinstock K., West A.P., Willey D.L., Whitehead S.L., Wilming L.,
RA   Wray P.W., Young L., Chen Y., Lovering R.C., Moschonas N.K.,
RA   Siebert R., Fechtel K., Bentley D., Durbin R.M., Hubbard T.,
RA   Doucette-Stamm L., Beck S., Smith D.R., Rogers J.;
RT   "The DNA sequence and comparative analysis of human chromosome 10.";
RL   Nature 429:375-381(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA], AND VARIANT PHE-39.
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANT PHE-39.
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [9]
RP   REVIEW.
RX   PubMed=11076395; DOI=10.1055/s-2000-9391;
RA   Keppler D., Koenig J.;
RT   "Hepatic secretion of conjugated drugs and endogenous substances.";
RL   Semin. Liver Dis. 20:265-272(2000).
RN   [10]
RP   MUTAGENESIS OF TRP-1254.
RX   PubMed=11500505; DOI=10.1074/jbc.M105160200;
RA   Ito K., Oleschuk C.J., Westlake C., Vasa M.Z., Deeley R.G.,
RA   Cole S.P.C.;
RT   "Mutation of Trp1254 in the multispecific organic anion transporter,
RT   multidrug resistance protein 2 (MRP2) (ABCC2), alters substrate
RT   specificity and results in loss of methotrexate transport activity.";
RL   J. Biol. Chem. 276:38108-38114(2001).
RN   [11]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of
RT   the kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [12]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-283 AND SER-878, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [13]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [14]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [15]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-926; SER-930 AND
RP   SER-938, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [16]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-878 AND SER-1438, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [17]
RP   VARIANT DJS TRP-768.
RX   PubMed=9425227; DOI=10.1093/hmg/7.2.203;
RA   Wada M., Toh S., Taniguchi K., Nakamura T., Uchiumi T., Kohno K.,
RA   Yoshida I., Kimura A., Sakisaka S., Adachi Y., Kuwano M.;
RT   "Mutations in the canalicular multispecific organic anion transporter
RT   (cMOAT) gene, a novel ABC transporter, in patients with
RT   hyperbilirubinemia II/Dubin-Johnson syndrome.";
RL   Hum. Mol. Genet. 7:203-207(1998).
RN   [18]
RP   VARIANTS DJS TRP-768 AND ARG-1382.
RX   PubMed=10053008; DOI=10.1086/302292;
RA   Toh S., Wada M., Uchiumi T., Inokuchi A., Makino Y., Horie Y.,
RA   Adachi Y., Sakisaka S., Kuwano M.;
RT   "Genomic structure of the canalicular multispecific organic anion-
RT   transporter gene (MRP2/cMOAT) and mutations in the ATP-binding-
RT   cassette region in Dubin-Johnson syndrome.";
RL   Am. J. Hum. Genet. 64:739-746(1999).
RN   [19]
RP   CHARACTERIZATION OF VARIANT DJS 1392-ARG-MET-1393 DEL, AND SUBCELLULAR
RP   LOCATION.
RX   PubMed=11093739; DOI=10.1053/jhep.2000.19791;
RA   Keitel V., Kartenbeck J., Nies A.T., Spring H., Brom M., Keppler D.;
RT   "Impaired protein maturation of the conjugate export pump multidrug
RT   resistance protein 2 as a consequence of a deletion mutation in Dubin-
RT   Johnson syndrome.";
RL   Hepatology 32:1317-1328(2000).
RN   [20]
RP   VARIANTS DJS HIS-1150 AND PHE-1173, AND VARIANTS ASN-281 AND ILE-417.
RX   PubMed=11477083; DOI=10.1074/jbc.M105047200;
RA   Mor-Cohen R., Zivelin A., Rosenberg N., Shani M., Muallem S.,
RA   Seligsohn U.;
RT   "Identification and functional analysis of two novel mutations in the
RT   multidrug resistance protein 2 gene in Israeli patients with Dubin-
RT   Johnson syndrome.";
RL   J. Biol. Chem. 276:36923-36930(2001).
RN   [21]
RP   VARIANT DJS TRP-768, AND VARIANTS ILE-417; PHE-789 AND THR-1450.
RX   PubMed=11266082; DOI=10.1097/00008571-200103000-00008;
RA   Ito S., Ieiri I., Tanabe M., Suzuki A., Higuchi S., Otsubo K.;
RT   "Polymorphism of the ABC transporter genes, MDR1, MRP1 and MRP2/cMOAT,
RT   in healthy Japanese subjects.";
RL   Pharmacogenetics 11:175-184(2001).
RN   [22]
RP   VARIANTS PHE-39; GLY-333; HIS-353; ILE-486; THR-670; SER-921;
RP   THR-1036; HIS-1174; LEU-1181; GLU-1188; LEU-1291 AND TYR-1515,
RP   CHARACTERIZATION OF VARIANTS DJS PHE-1173, AND CHARACTERIZATION OF
RP   VARIANTS GLY-333; HIS-353; ILE-486; SER-921; THR-1036; HIS-1174;
RP   LEU-1181; LYS-1244 AND LEU-1291.
RX   PubMed=22290738; DOI=10.1002/humu.22041;
RA   Arlanov R., Porter A., Strand D., Brough R., Karpova D., Kerb R.,
RA   Wojnowski L., Schwab M., Lang T.;
RT   "Functional characterization of protein variants of the human
RT   multidrug transporter ABCC2 by a novel targeted expression system in
RT   fibrosarcoma cells.";
RL   Hum. Mutat. 33:750-762(2012).
RN   [23]
RP   VARIANT DJS TRP-768, AND VARIANT ILE-417.
RX   PubMed=25336012; DOI=10.1111/ped.12404;
RA   Okada H., Kusaka T., Fuke N., Kunikata J., Kondo S., Iwase T., Nan W.,
RA   Hirota T., Ieiri I., Itoh S.;
RT   "Neonatal Dubin-Johnson syndrome: novel compound heterozygous mutation
RT   in the ABCC2 gene.";
RL   Pediatr. Int. 56:E62-E62(2014).
CC   -!- FUNCTION: Mediates hepatobiliary excretion of numerous organic
CC       anions. May function as a cellular cisplatin transporter.
CC   -!- INTERACTION:
CC       P19838:NFKB1; NbExp=3; IntAct=EBI-3916193, EBI-300010;
CC   -!- SUBCELLULAR LOCATION: Apical cell membrane
CC       {ECO:0000269|PubMed:11093739}; Multi-pass membrane protein
CC       {ECO:0000255|PROSITE-ProRule:PRU00441,
CC       ECO:0000269|PubMed:11093739}.
CC   -!- TISSUE SPECIFICITY: Expressed by polarized cells in liver, kidney
CC       and intestine. The highest expression is found in liver.
CC   -!- DISEASE: Dubin-Johnson syndrome (DJS) [MIM:237500]: Autosomal
CC       recessive disorder characterized by conjugated hyperbilirubinemia,
CC       an increase in the urinary excretion of coproporphyrin isomer I,
CC       deposition of melanin-like pigment in hepatocytes, and prolonged
CC       retention of sulfobromophthalein, but otherwise normal liver
CC       function. {ECO:0000269|PubMed:10053008,
CC       ECO:0000269|PubMed:10464142, ECO:0000269|PubMed:11093739,
CC       ECO:0000269|PubMed:11266082, ECO:0000269|PubMed:11477083,
CC       ECO:0000269|PubMed:22290738, ECO:0000269|PubMed:25336012,
CC       ECO:0000269|PubMed:9425227}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the ABC transporter superfamily. ABCC
CC       family. Conjugate transporter (TC 3.A.1.208) subfamily.
CC       {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=ABCMdb; Note=Database for mutations in ABC
CC       proteins;
CC       URL="http://abcmutations.hegelab.org/proteinDetails?uniprot_id=Q92887";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; U63970; AAB39892.1; -; mRNA.
DR   EMBL; U49248; AAB09422.1; -; mRNA.
DR   EMBL; X96395; CAA65259.2; -; mRNA.
DR   EMBL; AJ132244; CAB45309.1; -; Genomic_DNA.
DR   EMBL; AJ132287; CAB45309.1; JOINED; Genomic_DNA.
DR   EMBL; AJ245625; CAB45309.1; JOINED; Genomic_DNA.
DR   EMBL; AJ132288; CAB45309.1; JOINED; Genomic_DNA.
DR   EMBL; AJ132289; CAB45309.1; JOINED; Genomic_DNA.
DR   EMBL; AJ132290; CAB45309.1; JOINED; Genomic_DNA.
DR   EMBL; AJ132291; CAB45309.1; JOINED; Genomic_DNA.
DR   EMBL; AJ132292; CAB45309.1; JOINED; Genomic_DNA.
DR   EMBL; AJ132293; CAB45309.1; JOINED; Genomic_DNA.
DR   EMBL; AJ132294; CAB45309.1; JOINED; Genomic_DNA.
DR   EMBL; AJ132295; CAB45309.1; JOINED; Genomic_DNA.
DR   EMBL; AJ132296; CAB45309.1; JOINED; Genomic_DNA.
DR   EMBL; AJ132297; CAB45309.1; JOINED; Genomic_DNA.
DR   EMBL; AJ132298; CAB45309.1; JOINED; Genomic_DNA.
DR   EMBL; AJ132299; CAB45309.1; JOINED; Genomic_DNA.
DR   EMBL; AJ132300; CAB45309.1; JOINED; Genomic_DNA.
DR   EMBL; AJ132301; CAB45309.1; JOINED; Genomic_DNA.
DR   EMBL; AJ132302; CAB45309.1; JOINED; Genomic_DNA.
DR   EMBL; AJ132303; CAB45309.1; JOINED; Genomic_DNA.
DR   EMBL; AJ245626; CAB45309.1; JOINED; Genomic_DNA.
DR   EMBL; AJ132304; CAB45309.1; JOINED; Genomic_DNA.
DR   EMBL; AJ132305; CAB45309.1; JOINED; Genomic_DNA.
DR   EMBL; AJ132306; CAB45309.1; JOINED; Genomic_DNA.
DR   EMBL; AJ132307; CAB45309.1; JOINED; Genomic_DNA.
DR   EMBL; AJ132308; CAB45309.1; JOINED; Genomic_DNA.
DR   EMBL; AJ245627; CAB45309.1; JOINED; Genomic_DNA.
DR   EMBL; AJ132309; CAB45309.1; JOINED; Genomic_DNA.
DR   EMBL; AJ132310; CAB45309.1; JOINED; Genomic_DNA.
DR   EMBL; AJ132311; CAB45309.1; JOINED; Genomic_DNA.
DR   EMBL; AJ132312; CAB45309.1; JOINED; Genomic_DNA.
DR   EMBL; AJ132313; CAB45309.1; JOINED; Genomic_DNA.
DR   EMBL; AJ132314; CAB45309.1; JOINED; Genomic_DNA.
DR   EMBL; AL392107; CAI11010.1; -; Genomic_DNA.
DR   EMBL; AL133353; CAI11010.1; JOINED; Genomic_DNA.
DR   EMBL; AL133353; CAI14502.1; -; Genomic_DNA.
DR   EMBL; AL392107; CAI14502.1; JOINED; Genomic_DNA.
DR   EMBL; CH471066; EAW49853.1; -; Genomic_DNA.
DR   EMBL; BC136419; AAI36420.1; -; mRNA.
DR   CCDS; CCDS7484.1; -.
DR   PIR; S71841; S71841.
DR   RefSeq; NP_000383.1; NM_000392.4.
DR   UniGene; Hs.368243; -.
DR   ProteinModelPortal; Q92887; -.
DR   SMR; Q92887; -.
DR   BioGrid; 107647; 45.
DR   IntAct; Q92887; 5.
DR   MINT; MINT-5004989; -.
DR   STRING; 9606.ENSP00000359478; -.
DR   BindingDB; Q92887; -.
DR   ChEMBL; CHEMBL5748; -.
DR   DrugBank; DB04789; 5-methyltetrahydrofolic acid.
DR   DrugBank; DB00171; Adenosine triphosphate.
DR   DrugBank; DB00345; Aminohippuric acid.
DR   DrugBank; DB01169; Arsenic trioxide.
DR   DrugBank; DB01076; Atorvastatin.
DR   DrugBank; DB09060; Avibactam.
DR   DrugBank; DB08907; Canagliflozin.
DR   DrugBank; DB00564; Carbamazepine.
DR   DrugBank; DB00958; Carboplatin.
DR   DrugBank; DB00439; Cerivastatin.
DR   DrugBank; DB02659; Cholic Acid.
DR   DrugBank; DB00515; Cisplatin.
DR   DrugBank; DB00257; Clotrimazole.
DR   DrugBank; DB00286; Conjugated Equine Estrogens.
DR   DrugBank; DB00091; Cyclosporine.
DR   DrugBank; DB00694; Daunorubicin.
DR   DrugBank; DB01234; Dexamethasone.
DR   DrugBank; DB01248; Docetaxel.
DR   DrugBank; DB00997; Doxorubicin.
DR   DrugBank; DB09272; Eluxadoline.
DR   DrugBank; DB00876; Eprosartan.
DR   DrugBank; DB00977; Ethinyl Estradiol.
DR   DrugBank; DB00773; Etoposide.
DR   DrugBank; DB00973; Ezetimibe.
DR   DrugBank; DB00695; Furosemide.
DR   DrugBank; DB02703; Fusidic Acid.
DR   DrugBank; DB08884; Gadoxetic acid.
DR   DrugBank; DB00143; Glutathione.
DR   DrugBank; DB01016; Glyburide.
DR   DrugBank; DB00365; Grepafloxacin.
DR   DrugBank; DB01892; Hyperforin.
DR   DrugBank; DB00224; Indinavir.
DR   DrugBank; DB00328; Indomethacin.
DR   DrugBank; DB00762; Irinotecan.
DR   DrugBank; DB00602; Ivermectin.
DR   DrugBank; DB00709; Lamivudine.
DR   DrugBank; DB01202; Levetiracetam.
DR   DrugBank; DB00978; Lomefloxacin.
DR   DrugBank; DB00227; Lovastatin.
DR   DrugBank; DB00563; Methotrexate.
DR   DrugBank; DB00688; Mycophenolate mofetil.
DR   DrugBank; DB01115; Nifedipine.
DR   DrugBank; DB00957; Norgestimate.
DR   DrugBank; DB01165; Ofloxacin.
DR   DrugBank; DB00275; Olmesartan.
DR   DrugBank; DB00526; Oxaliplatin.
DR   DrugBank; DB01229; Paclitaxel.
DR   DrugBank; DB01174; Phenobarbital.
DR   DrugBank; DB00252; Phenytoin.
DR   DrugBank; DB08860; Pitavastatin.
DR   DrugBank; DB01411; Pranlukast.
DR   DrugBank; DB00175; Pravastatin.
DR   DrugBank; DB01032; Probenecid.
DR   DrugBank; DB04216; Quercetin.
DR   DrugBank; DB00908; Quinidine.
DR   DrugBank; DB00206; Reserpine.
DR   DrugBank; DB01045; Rifampicin.
DR   DrugBank; DB00503; Ritonavir.
DR   DrugBank; DB01232; Saquinavir.
DR   DrugBank; DB00641; Simvastatin.
DR   DrugBank; DB00398; Sorafenib.
DR   DrugBank; DB01208; Sparfloxacin.
DR   DrugBank; DB00421; Spironolactone.
DR   DrugBank; DB00795; Sulfasalazine.
DR   DrugBank; DB01138; Sulfinpyrazone.
DR   DrugBank; DB01268; Sunitinib.
DR   DrugBank; DB00675; Tamoxifen.
DR   DrugBank; DB04348; Taurocholic Acid.
DR   DrugBank; DB00966; Telmisartan.
DR   DrugBank; DB00300; Tenofovir.
DR   DrugBank; DB00116; Tetrahydrofolic acid.
DR   DrugBank; DB01586; Ursodeoxycholic acid.
DR   DrugBank; DB00067; Vasopressin.
DR   DrugBank; DB00661; Verapamil.
DR   DrugBank; DB00570; Vinblastine.
DR   DrugBank; DB00541; Vincristine.
DR   GuidetoPHARMACOLOGY; 780; -.
DR   SwissLipids; SLP:000001599; -.
DR   TCDB; 3.A.1.208.2; the atp-binding cassette (abc) superfamily.
DR   iPTMnet; Q92887; -.
DR   PhosphoSitePlus; Q92887; -.
DR   BioMuta; ABCC2; -.
DR   DMDM; 308153583; -.
DR   EPD; Q92887; -.
DR   MaxQB; Q92887; -.
DR   PaxDb; Q92887; -.
DR   PeptideAtlas; Q92887; -.
DR   PRIDE; Q92887; -.
DR   Ensembl; ENST00000370449; ENSP00000359478; ENSG00000023839.
DR   GeneID; 1244; -.
DR   KEGG; hsa:1244; -.
DR   UCSC; uc001kqf.3; human.
DR   CTD; 1244; -.
DR   DisGeNET; 1244; -.
DR   GeneCards; ABCC2; -.
DR   HGNC; HGNC:53; ABCC2.
DR   HPA; CAB037271; -.
DR   HPA; HPA004860; -.
DR   MalaCards; ABCC2; -.
DR   MIM; 237500; phenotype.
DR   MIM; 601107; gene.
DR   neXtProt; NX_Q92887; -.
DR   OpenTargets; ENSG00000023839; -.
DR   Orphanet; 234; Dubin-Johnson syndrome.
DR   PharmGKB; PA116; -.
DR   eggNOG; KOG0054; Eukaryota.
DR   eggNOG; COG1132; LUCA.
DR   GeneTree; ENSGT00860000133687; -.
DR   HOVERGEN; HBG108314; -.
DR   InParanoid; Q92887; -.
DR   KO; K05666; -.
DR   OMA; QTPGPFY; -.
DR   OrthoDB; EOG091G00IN; -.
DR   PhylomeDB; Q92887; -.
DR   TreeFam; TF105199; -.
DR   Reactome; R-HSA-382556; ABC-family proteins mediated transport.
DR   SABIO-RK; Q92887; -.
DR   ChiTaRS; ABCC2; human.
DR   GeneWiki; Multidrug_resistance-associated_protein_2; -.
DR   GenomeRNAi; 1244; -.
DR   PRO; PR:Q92887; -.
DR   Proteomes; UP000005640; Chromosome 10.
DR   Bgee; ENSG00000023839; -.
DR   CleanEx; HS_ABCC2; -.
DR   ExpressionAtlas; Q92887; baseline and differential.
DR   Genevisible; Q92887; HS.
DR   GO; GO:0016324; C:apical plasma membrane; IDA:UniProtKB.
DR   GO; GO:0031526; C:brush border membrane; IEA:Ensembl.
DR   GO; GO:0009986; C:cell surface; IDA:UniProtKB.
DR   GO; GO:0005887; C:integral component of plasma membrane; IBA:GO_Central.
DR   GO; GO:0046581; C:intercellular canaliculus; IEA:Ensembl.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0042626; F:ATPase activity, coupled to transmembrane movement of substances; TAS:ProtInc.
DR   GO; GO:0043225; F:ATPase-coupled anion transmembrane transporter activity; TAS:Reactome.
DR   GO; GO:0015127; F:bilirubin transmembrane transporter activity; TAS:Reactome.
DR   GO; GO:0008514; F:organic anion transmembrane transporter activity; TAS:ProtInc.
DR   GO; GO:0019904; F:protein domain specific binding; IEA:Ensembl.
DR   GO; GO:1901086; P:benzylpenicillin metabolic process; IEA:Ensembl.
DR   GO; GO:0015722; P:canalicular bile acid transport; IEA:Ensembl.
DR   GO; GO:0030644; P:cellular chloride ion homeostasis; IEA:Ensembl.
DR   GO; GO:0071549; P:cellular response to dexamethasone stimulus; IEA:Ensembl.
DR   GO; GO:0032870; P:cellular response to hormone stimulus; IBA:GO_Central.
DR   GO; GO:0071347; P:cellular response to interleukin-1; IEA:Ensembl.
DR   GO; GO:0071354; P:cellular response to interleukin-6; IEA:Ensembl.
DR   GO; GO:0071222; P:cellular response to lipopolysaccharide; IEA:Ensembl.
DR   GO; GO:0071356; P:cellular response to tumor necrosis factor; IEA:Ensembl.
DR   GO; GO:0006855; P:drug transmembrane transport; IEA:Ensembl.
DR   GO; GO:0007565; P:female pregnancy; IEA:Ensembl.
DR   GO; GO:0015694; P:mercury ion transport; IEA:Ensembl.
DR   GO; GO:0015732; P:prostaglandin transport; IEA:Ensembl.
DR   GO; GO:0097327; P:response to antineoplastic agent; IEA:Ensembl.
DR   GO; GO:0046685; P:response to arsenic-containing substance; IEA:Ensembl.
DR   GO; GO:0043627; P:response to estrogen; IEA:Ensembl.
DR   GO; GO:0009408; P:response to heat; IEA:Ensembl.
DR   GO; GO:0031427; P:response to methotrexate; IEA:Ensembl.
DR   GO; GO:0006979; P:response to oxidative stress; IEA:Ensembl.
DR   GO; GO:0070327; P:thyroid hormone transport; IEA:Ensembl.
DR   GO; GO:0055085; P:transmembrane transport; TAS:Reactome.
DR   GO; GO:0006810; P:transport; TAS:ProtInc.
DR   InterPro; IPR003593; AAA+_ATPase.
DR   InterPro; IPR011527; ABC1_TM_dom.
DR   InterPro; IPR003439; ABC_transporter-like.
DR   InterPro; IPR017871; ABC_transporter_CS.
DR   InterPro; IPR030247; ABCC2.
DR   InterPro; IPR005292; Multidrug-R_assoc.
DR   InterPro; IPR027417; P-loop_NTPase.
DR   PANTHER; PTHR24223:SF276; PTHR24223:SF276; 1.
DR   Pfam; PF00664; ABC_membrane; 2.
DR   Pfam; PF00005; ABC_tran; 2.
DR   SMART; SM00382; AAA; 2.
DR   SUPFAM; SSF52540; SSF52540; 2.
DR   SUPFAM; SSF90123; SSF90123; 2.
DR   TIGRFAMs; TIGR00957; MRP_assoc_pro; 1.
DR   PROSITE; PS50929; ABC_TM1F; 2.
DR   PROSITE; PS00211; ABC_TRANSPORTER_1; 1.
DR   PROSITE; PS50893; ABC_TRANSPORTER_2; 2.
PE   1: Evidence at protein level;
KW   ATP-binding; Cell membrane; Complete proteome; Disease mutation;
KW   Glycoprotein; Membrane; Nucleotide-binding; Phosphoprotein;
KW   Polymorphism; Reference proteome; Repeat; Transmembrane;
KW   Transmembrane helix; Transport.
FT   CHAIN         1   1545       Canalicular multispecific organic anion
FT                                transporter 1.
FT                                /FTId=PRO_0000093356.
FT   TOPO_DOM      1     27       Extracellular. {ECO:0000250}.
FT   TRANSMEM     28     48       Helical; Name=1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00441}.
FT   TOPO_DOM     49     68       Cytoplasmic. {ECO:0000250}.
FT   TRANSMEM     69     89       Helical; Name=2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00441}.
FT   TOPO_DOM     90     93       Extracellular. {ECO:0000250}.
FT   TRANSMEM     94    114       Helical; Name=3. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00441}.
FT   TOPO_DOM    115    126       Cytoplasmic. {ECO:0000250}.
FT   TRANSMEM    127    147       Helical; Name=4. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00441}.
FT   TOPO_DOM    148    165       Extracellular. {ECO:0000250}.
FT   TRANSMEM    166    186       Helical; Name=5. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00441}.
FT   TOPO_DOM    187    313       Cytoplasmic. {ECO:0000250}.
FT   TRANSMEM    314    334       Helical; Name=6. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00441}.
FT   TOPO_DOM    335    360       Extracellular. {ECO:0000250}.
FT   TRANSMEM    361    381       Helical; Name=7. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00441}.
FT   TOPO_DOM    382    437       Cytoplasmic. {ECO:0000250}.
FT   TRANSMEM    438    458       Helical; Name=8. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00441}.
FT   TOPO_DOM    459    461       Extracellular. {ECO:0000250}.
FT   TRANSMEM    462    482       Helical; Name=9. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00441}.
FT   TOPO_DOM    483    544       Cytoplasmic. {ECO:0000250}.
FT   TRANSMEM    545    565       Helical; Name=10. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00441}.
FT   TOPO_DOM    566    587       Extracellular. {ECO:0000250}.
FT   TRANSMEM    588    608       Helical; Name=11. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00441}.
FT   TOPO_DOM    609    971       Cytoplasmic. {ECO:0000250}.
FT   TRANSMEM    972    992       Helical; Name=12. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00441}.
FT   TOPO_DOM    993   1033       Extracellular. {ECO:0000250}.
FT   TRANSMEM   1034   1054       Helical; Name=13. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00441}.
FT   TOPO_DOM   1055   1097       Cytoplasmic. {ECO:0000250}.
FT   TRANSMEM   1098   1118       Helical; Name=14. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00441}.
FT   TOPO_DOM   1119   1119       Extracellular. {ECO:0000250}.
FT   TRANSMEM   1120   1140       Helical; Name=15. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00441}.
FT   TOPO_DOM   1141   1211       Cytoplasmic. {ECO:0000250}.
FT   TRANSMEM   1212   1232       Helical; Name=16. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00441}.
FT   TOPO_DOM   1233   1234       Extracellular. {ECO:0000250}.
FT   TRANSMEM   1235   1255       Helical; Name=17. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00441}.
FT   TOPO_DOM   1256   1545       Cytoplasmic. {ECO:0000250}.
FT   DOMAIN      322    605       ABC transmembrane type-1 1.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00441}.
FT   DOMAIN      637    861       ABC transporter 1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00434}.
FT   DOMAIN      979   1264       ABC transmembrane type-1 2.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00441}.
FT   DOMAIN     1300   1534       ABC transporter 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00434}.
FT   NP_BIND     671    678       ATP 1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00434}.
FT   NP_BIND    1334   1341       ATP 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00434}.
FT   MOD_RES     281    281       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q63120}.
FT   MOD_RES     283    283       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648}.
FT   MOD_RES     878    878       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:24275569}.
FT   MOD_RES     926    926       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     930    930       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     938    938       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES    1438   1438       Phosphoserine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   CARBOHYD      7      7       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD     12     12       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   1011   1011       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   VARIANT      39     39       Y -> F (in dbSNP:rs927344).
FT                                {ECO:0000269|PubMed:10464142,
FT                                ECO:0000269|PubMed:15489334,
FT                                ECO:0000269|PubMed:22290738,
FT                                ECO:0000269|PubMed:8662992,
FT                                ECO:0000269|PubMed:8797578,
FT                                ECO:0000269|Ref.2, ECO:0000269|Ref.7}.
FT                                /FTId=VAR_047152.
FT   VARIANT     246    246       M -> L (in dbSNP:rs17222744).
FT                                /FTId=VAR_029113.
FT   VARIANT     281    281       S -> N (in dbSNP:rs56131651).
FT                                {ECO:0000269|PubMed:11477083}.
FT                                /FTId=VAR_013324.
FT   VARIANT     333    333       D -> G (decreased expression; altered
FT                                subcellular localization; altered
FT                                transporter activity; dbSNP:rs17222674).
FT                                {ECO:0000269|PubMed:22290738}.
FT                                /FTId=VAR_020226.
FT   VARIANT     353    353       R -> H (altered transporter activity;
FT                                dbSNP:rs7080681).
FT                                {ECO:0000269|PubMed:22290738}.
FT                                /FTId=VAR_020227.
FT   VARIANT     417    417       V -> I (in dbSNP:rs2273697).
FT                                {ECO:0000269|PubMed:11266082,
FT                                ECO:0000269|PubMed:11477083,
FT                                ECO:0000269|PubMed:25336012}.
FT                                /FTId=VAR_013325.
FT   VARIANT     486    486       T -> I (altered transporter activity;
FT                                dbSNP:rs17222589).
FT                                {ECO:0000269|PubMed:22290738}.
FT                                /FTId=VAR_070607.
FT   VARIANT     495    495       K -> E (in dbSNP:rs17222561).
FT                                /FTId=VAR_029115.
FT   VARIANT     562    562       F -> L (in dbSNP:rs17216233).
FT                                /FTId=VAR_029116.
FT   VARIANT     670    670       I -> T (in dbSNP:rs17222632).
FT                                {ECO:0000269|PubMed:22290738}.
FT                                /FTId=VAR_020228.
FT   VARIANT     768    768       R -> W (in DJS; dbSNP:rs56199535).
FT                                {ECO:0000269|PubMed:10053008,
FT                                ECO:0000269|PubMed:11266082,
FT                                ECO:0000269|PubMed:25336012,
FT                                ECO:0000269|PubMed:9425227}.
FT                                /FTId=VAR_000099.
FT   VARIANT     789    789       S -> F (in dbSNP:rs56220353).
FT                                {ECO:0000269|PubMed:11266082}.
FT                                /FTId=VAR_013326.
FT   VARIANT     849    849       L -> R (in dbSNP:rs17222617).
FT                                /FTId=VAR_020229.
FT   VARIANT     921    921       G -> S (altered transporter activity;
FT                                dbSNP:rs41318029).
FT                                {ECO:0000269|PubMed:22290738}.
FT                                /FTId=VAR_070608.
FT   VARIANT     982    982       I -> V (in dbSNP:rs17222554).
FT                                /FTId=VAR_029117.
FT   VARIANT    1036   1036       I -> T (polymorphism; no effect on
FT                                transporter activity; dbSNP:rs45441199).
FT                                {ECO:0000269|PubMed:22290738}.
FT                                /FTId=VAR_020230.
FT   VARIANT    1063   1063       N -> S (in dbSNP:rs17222540).
FT                                /FTId=VAR_029118.
FT   VARIANT    1150   1150       R -> H (in DJS; protein is properly
FT                                localized at the plasma membrane, but
FT                                transporter activity is impaired;
FT                                dbSNP:rs72558200).
FT                                {ECO:0000269|PubMed:11477083}.
FT                                /FTId=VAR_013327.
FT   VARIANT    1173   1173       I -> F (in DJS; decreased expression and
FT                                mislocation to the endoplasmic reticulum;
FT                                dbSNP:rs72558201).
FT                                {ECO:0000269|PubMed:11477083,
FT                                ECO:0000269|PubMed:22290738}.
FT                                /FTId=VAR_013328.
FT   VARIANT    1174   1174       R -> H (decreased expression; altered
FT                                subcellular localization; decreased
FT                                transporter activity; dbSNP:rs139188247).
FT                                {ECO:0000269|PubMed:22290738}.
FT                                /FTId=VAR_070609.
FT   VARIANT    1181   1181       R -> L (decreased expression;
FT                                dbSNP:rs8187692).
FT                                {ECO:0000269|PubMed:22290738}.
FT                                /FTId=VAR_020231.
FT   VARIANT    1188   1188       V -> E (in dbSNP:rs17222723).
FT                                {ECO:0000269|PubMed:22290738,
FT                                ECO:0000269|Ref.2}.
FT                                /FTId=VAR_020232.
FT   VARIANT    1244   1244       N -> K (decreased transporter activity;
FT                                dbSNP:rs757141905).
FT                                {ECO:0000269|PubMed:22290738}.
FT                                /FTId=VAR_070610.
FT   VARIANT    1273   1273       T -> A (in dbSNP:rs8187699).
FT                                /FTId=VAR_024360.
FT   VARIANT    1291   1291       P -> L (altered transporter activity;
FT                                dbSNP:rs17216317).
FT                                {ECO:0000269|PubMed:22290738}.
FT                                /FTId=VAR_020233.
FT   VARIANT    1382   1382       Q -> R (in DJS; dbSNP:rs72558202).
FT                                {ECO:0000269|PubMed:10053008}.
FT                                /FTId=VAR_010756.
FT   VARIANT    1392   1393       Missing (in DJS; impaired transport from
FT                                the endoplasmic reticulum to the apical
FT                                plasma membrane associated with impaired
FT                                maturation).
FT                                {ECO:0000269|PubMed:10464142,
FT                                ECO:0000269|PubMed:11093739}.
FT                                /FTId=VAR_013329.
FT   VARIANT    1450   1450       A -> T (in dbSNP:rs56296335).
FT                                {ECO:0000269|PubMed:11266082}.
FT                                /FTId=VAR_013330.
FT   VARIANT    1515   1515       C -> Y (in dbSNP:rs8187710).
FT                                {ECO:0000269|PubMed:22290738,
FT                                ECO:0000269|Ref.2}.
FT                                /FTId=VAR_020234.
FT   MUTAGEN    1254   1254       W->A,C: Fails to transport methotrexate,
FT                                leukotriene C4 and estradiol glucuronide.
FT                                {ECO:0000269|PubMed:11500505}.
FT   MUTAGEN    1254   1254       W->F: Fails to transport methotrexate and
FT                                leukotriene C4. Does not affect estradiol
FT                                glucuronide transport.
FT                                {ECO:0000269|PubMed:11500505}.
FT   MUTAGEN    1254   1254       W->Y: Fails to transport methotrexate;
FT                                reduces leukotriene C4 transport. Does
FT                                not affect estradiol glucuronide
FT                                transport. {ECO:0000269|PubMed:11500505}.
FT   CONFLICT   1430   1430       V -> G (in Ref. 5; CAB45309).
FT                                {ECO:0000305}.
SQ   SEQUENCE   1545 AA;  174207 MW;  C5F8984FFCDF9799 CRC64;
     MLEKFCNSTF WNSSFLDSPE ADLPLCFEQT VLVWIPLGYL WLLAPWQLLH VYKSRTKRSS
     TTKLYLAKQV FVGFLLILAA IELALVLTED SGQATVPAVR YTNPSLYLGT WLLVLLIQYS
     RQWCVQKNSW FLSLFWILSI LCGTFQFQTL IRTLLQGDNS NLAYSCLFFI SYGFQILILI
     FSAFSENNES SNNPSSIASF LSSITYSWYD SIILKGYKRP LTLEDVWEVD EEMKTKTLVS
     KFETHMKREL QKARRALQRR QEKSSQQNSG ARLPGLNKNQ SQSQDALVLE DVEKKKKKSG
     TKKDVPKSWL MKALFKTFYM VLLKSFLLKL VNDIFTFVSP QLLKLLISFA SDRDTYLWIG
     YLCAILLFTA ALIQSFCLQC YFQLCFKLGV KVRTAIMASV YKKALTLSNL ARKEYTVGET
     VNLMSVDAQK LMDVTNFMHM LWSSVLQIVL SIFFLWRELG PSVLAGVGVM VLVIPINAIL
     STKSKTIQVK NMKNKDKRLK IMNEILSGIK ILKYFAWEPS FRDQVQNLRK KELKNLLAFS
     QLQCVVIFVF QLTPVLVSVV TFSVYVLVDS NNILDAQKAF TSITLFNILR FPLSMLPMMI
     SSMLQASVST ERLEKYLGGD DLDTSAIRHD CNFDKAMQFS EASFTWEHDS EATVRDVNLD
     IMAGQLVAVI GPVGSGKSSL ISAMLGEMEN VHGHITIKGT TAYVPQQSWI QNGTIKDNIL
     FGTEFNEKRY QQVLEACALL PDLEMLPGGD LAEIGEKGIN LSGGQKQRIS LARATYQNLD
     IYLLDDPLSA VDAHVGKHIF NKVLGPNGLL KGKTRLLVTH SMHFLPQVDE IVVLGNGTIV
     EKGSYSALLA KKGEFAKNLK TFLRHTGPEE EATVHDGSEE EDDDYGLISS VEEIPEDAAS
     ITMRRENSFR RTLSRSSRSN GRHLKSLRNS LKTRNVNSLK EDEELVKGQK LIKKEFIETG
     KVKFSIYLEY LQAIGLFSIF FIILAFVMNS VAFIGSNLWL SAWTSDSKIF NSTDYPASQR
     DMRVGVYGAL GLAQGIFVFI AHFWSAFGFV HASNILHKQL LNNILRAPMR FFDTTPTGRI
     VNRFAGDIST VDDTLPQSLR SWITCFLGII STLVMICMAT PVFTIIVIPL GIIYVSVQMF
     YVSTSRQLRR LDSVTRSPIY SHFSETVSGL PVIRAFEHQQ RFLKHNEVRI DTNQKCVFSW
     ITSNRWLAIR LELVGNLTVF FSALMMVIYR DTLSGDTVGF VLSNALNITQ TLNWLVRMTS
     EIETNIVAVE RITEYTKVEN EAPWVTDKRP PPDWPSKGKI QFNNYQVRYR PELDLVLRGI
     TCDIGSMEKI GVVGRTGAGK SSLTNCLFRI LEAAGGQIII DGVDIASIGL HDLREKLTII
     PQDPILFSGS LRMNLDPFNN YSDEEIWKAL ELAHLKSFVA SLQLGLSHEV TEAGGNLSIG
     QRQLLCLGRA LLRKSKILVL DEATAAVDLE TDNLIQTTIQ NEFAHCTVIT IAHRLHTIMD
     SDKVMVLDNG KIIECGSPEE LLQIPGPFYF MAKEAGIENV NSTKF
//
